Lopid Side Effects
Generic Name: Gemfibrozil
Please note - some side effects for Lopid may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
|
For the consumer For the professional
|
|
Side Effects of Lopid - for the consumer
Lopid
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Lopid:
Seek medical attention right away if any of these SEVERE side effects occur when using Lopid:Blurred vision; diarrhea; dizziness; gas; headache; indigestion; nausea; stomach pain; tiredness; vomiting.
TopSevere allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); diarrhea; muscle pain; nausea; persistent or severe stomach pain; tenderness; vomiting; weakness.
For the professional
Lopid
In the double-blind controlled phase of the primary prevention component of the Helsinki Heart Study, 2046 patients received Lopid for up to five years. In that study, the following adverse reactions were statistically more frequent in subjects in the Lopid group:
| Lopid (N = 2046) |
PLACEBO (N = 2035) |
|
|---|---|---|
| Frequency in percent of subjects |
||
| Gastrointestinal reactions | 34.2 | 23.8 |
| Dyspepsia | 19.6 | 11.9 |
| Abdominal pain | 9.8 | 5.6 |
| Acute appendicitis | 1.2 | 0.6 |
| (histologically confirmed in most cases where data were available) |
||
| Atrial fibrillation | 0.7 | 0.1 |
| Adverse events reported by more than 1% of subjects, but without a significant difference between groups: | ||
| Diarrhea | 7.2 | 6.5 |
| Fatigue | 3.8 | 3.5 |
| Nausea/Vomiting | 2.5 | 2.1 |
| Eczema | 1.9 | 1.2 |
| Rash | 1.7 | 1.3 |
| Vertigo | 1.5 | 1.3 |
| Constipation | 1.4 | 1.3 |
| Headache | 1.2 | 1.1 |
Gallbladder surgery was performed in 0.9% of Lopid and 0.5% of placebo subjects in the primary prevention component, a 64% excess, which is not statistically different from the excess of gallbladder surgery observed in the clofibrate compared to the placebo group of the WHO study. Gallbladder surgery was also performed more frequently in the Lopid group compared to placebo (1.9% vs 0.3%, p=0.07) in the secondary prevention component. A statistically significant increase in appendectomy in the gemfibrozil group was seen also in the secondary prevention component (6 on gemfibrozil vs 0 on placebo, p=0.014).
Nervous system and special senses adverse reactions were more common in the Lopid group. These included hypesthesia, paresthesias, and taste perversion. Other adverse reactions that were more common among Lopid treatment group subjects but where a causal relationship was not established include cataracts, peripheral vascular disease, and intracerebral hemorrhage.
From other studies it seems probable that Lopid is causally related to the occurrence of MUSCULOSKELETAL SYMPTOMS, and to ABNORMAL LIVER FUNCTION TESTS and HEMATOLOGIC CHANGES.
Reports of viral and bacterial infections (common cold, cough, urinary tract infections) were more common in gemfibrozil treated patients in other controlled clinical trials of 805 patients. Additional adverse reactions that have been reported for gemfibrozil are listed below by system. These are categorized according to whether a causal relationship to treatment with Lopid is probable or not established:
| CAUSAL RELATIONSHIP PROBABLE |
CAUSAL RELATIONSHIP NOT ESTABLISHED |
|
|---|---|---|
| General: Cardiac: |
weight loss extrasystoles |
|
| Gastrointestinal: | cholestatic jaundice | pancreatitis hepatoma colitis |
| Central Nervous | ||
| System: | dizziness somnolence paresthesia peripheral neuritis decreased libido depression headache |
confusion convulsions syncope |
| Eye: | blurred vision | retinal edema |
| Genitourinary: | impotence | decreased male fertility renal dysfunction |
| Musculoskeletal: | myopathy myasthenia myalgia painful extremities arthralgia synovitis rhabdomyolysis |
|
| Clinical | ||
| Laboratory: | increased creatine phosphokinase increased bilirubin increased liver transaminases (AST [SGOT], ALT [SGPT]) increased alkaline phosphatase |
positive antinuclear antibody |
| Hematopoietic: | anemia leukopenia bone marrow hypoplasia eosinophilia |
thrombocytopenia |
| Immunologic: | angioedema laryngeal edema urticaria |
anaphylaxis Lupus-like syndrome vasculitis |
| Integumentary: | exfoliative dermatitis rash dermatitis pruritus |
alopecia photosensitivity |
Additional adverse reactions that have been reported include cholecystitis and cholelithiasis (ref. 12).
TopMore resources:
Lopid - Includes detailed dosage instructions.
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
